European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Clinical genetics<br />
tion, cardiac malformations, cranio-facial dysmorphisms and pigmentary<br />
skin anomalies following the lines of Blaschko. The chromosomal<br />
analysis of peripheral blood cells was normal, but 69,XXY/46,XY mosaicism<br />
was detected in skin fibroblast culture.A thorough examination<br />
of the patient at the age of <strong>16</strong> revealed the usual features typical<br />
for this type of chromosomal mosaicism (asymmetric face, prominent<br />
and wide nasal bridge, clinodactyly, mental retardation, hypotonia,<br />
patchy pigmentation and depigmentation of skin, cardiac malformations,<br />
and truncular obesity), but also the absence of one of the inferior<br />
incisors and alternating vertical bands of opaque white and translucent<br />
enamel most evident on the central and lateral incisors. These<br />
dental abnormalities represent the anatomic equivalent of cutaneous<br />
Blaschko lines. Extracutaneous analogies of Blaschko lines have been<br />
described in various organs, such as the brain, bone, lens and teeth.<br />
These lines do not follow any known nervous, vascular or lymphatic<br />
structures but do follow and represent the developmental growth pattern<br />
of the skin. The embryological basis of these lines has not up to<br />
now been elucidated.<br />
P0037. Blepharophimosis, Ptosis, and Epicantus inversus<br />
Syndrome (BPES). Clinical study about three cases<br />
L. I. Butnariu 1 , C. Rusu 1 , M. Covic 1 , V. Gorduza 1 , L. Trandafir 2 ;<br />
1 University of Medicine and Pharmacy “Gr. T. Popa”, Department of <strong>Human</strong><br />
<strong>Genetics</strong>, Iassy, Romania, 2 University of Medicine and Pharmacy “Gr. T. Popa”,<br />
“Saint Mary” Children Hospital, Iassy, Romania.<br />
BPES is a rare autosomal dominant disease (less than 1:5,000). It is<br />
a complex eyelid malformation invariably characterized by four major<br />
features: blepharophimosis, ptosis, epicantus inversus and telecanthus.<br />
There are two types of BPES: type I associate the typical features<br />
with female infertility caused by premature ovarian failure and<br />
type II includes only palpebral anomalies.<br />
We present two familial and one sporadic case of BPES. The diagnosis<br />
was based by clinical signs.<br />
Case 1, sporadic, G.L, male, 1 years old. There are no other relatives<br />
affected. We note, normal pregnancy, newborn haemolytic disease,<br />
febrile seizures and spastic tetraparesis. Clinical and paraclinic evaluation<br />
revealed: typical BPES features, low-set ears, narrow external<br />
auditory meatus, bifid uvula, internal hydrocephaly, atrial septal defect<br />
and developmental delay.<br />
Case 2, I.B, male, 6 years old, present clinical features of BPES type<br />
I, like his own father; his mother had sensorineural hypoacusy. Other<br />
features are tall stature, sparse hair, normal intelect. There are no<br />
other relatives affected.<br />
Case 3, A.D, female,1 years old, present on clinical evaluation typical<br />
ocular features, low nasal bridge, low-set ears and normal intelect. The<br />
father and other 7 relatives on paternal side (males and females) have<br />
the same features of BPES type I: only males are transmitting, affected<br />
females are infertile. The karyotype was normal in all three patients.<br />
In conclusion, we emphasize the importance of the clinical features for<br />
diagnosis, leading further to an apropiate management.<br />
P0038. Changes in Phenotype of Bloom´s Syndrome with New<br />
Manifestations in Adult Individuals<br />
E. Passarge, H. Löser;<br />
Institut für <strong>Human</strong>genetik, Universitätsklinikum Essen, Essen, Germany.<br />
Bloom´s syndrome results from autosomal recessive mutations in the<br />
BLM gene located on human chromosome 15 at 15q26.1, encoding<br />
a DNA helicase with homology to RecQ in E. coli (MIM 210900). Its<br />
phenotype includes (i) pre- and postnatal growth retardation, (ii) facial<br />
features with dolichocephaly and a narrow face, (iii) light-sensitive<br />
facial telangiectasia in most patients, (iv) manifestations of genomic<br />
instability as revealed by a 10-fold increase of spontaneous sister<br />
chromatid exchanges, breaks and homologous exchanges between<br />
chromosomes, and an increased rate of somatic mutations. Affected<br />
individuals develop similar types of cancer as in the population, but<br />
at a much younger age (about 1 in 4). We have observed the natural<br />
history in 15 individuals with Bloom´s syndrome during the past 38<br />
years in Germany. We found that the phenotype in adult individuals<br />
becomes less distinctive with age than it is in children. In spite of persistent<br />
feeding difficulties, such as lack of appetite or regurgitation,<br />
adult individuals tend to gain weight. A new finding is development of<br />
diabetes mellitus type 1 or type 2. This has been observed in 27 of 117<br />
patients (23%) of individuals in the Bloom´s Syndrome Registry (J.<br />
German, M. Sanz, E. Passarge, unpublished data). The skin manifestations<br />
tend to improve with age. We conclude that the phenotype of<br />
Bloom´s syndrome is wider than recorded previously. It remains to be<br />
seen whether the molecular type of mutation present in an individual<br />
influences the phenotype.<br />
We thank J. German, N.A. Ellis, and M. Sanz, New York, for cooperation<br />
and mutational analysis.<br />
P0039. Implementation of a new high throughput sequencing<br />
service for BRCA1 and BRCA2 gene screening to comply with<br />
UK Government <strong>Genetics</strong> White Paper 40 day turnaround time<br />
Y. Wallis, N. Motton, N. Morrell, C. Morgan, E. Ormshaw, J. Bell, F. Macdonald;<br />
West Midlands Regional <strong>Genetics</strong> Service, Birmingham, United Kingdom.<br />
In response to UK Government targets for BRCA gene screening (<strong>Genetics</strong><br />
White Paper) the West Midlands Regional Diagnostic <strong>Genetics</strong><br />
Laboratory (Birmingham, UK) devised a novel sequencing-based<br />
strategy to screen the large BRCA1 and BRCA2 genes. The strategy is<br />
plate-based therefore facilitating the use of highly automated processes.<br />
63 new primer sets were designed to amplify the coding regions of<br />
both BRCA1 and BRCA2 genes simultaneously using a 2-plate system<br />
for each patient panel. Between September 2005 and January <strong>2007</strong><br />
a total of 731 diagnostic BRCA reports were issued as a result of the<br />
high throughput sequencing strategy. More than 98% of these reports<br />
were issued within 40 working days (from the date of sample receipt<br />
to date of report authorisation) with an average turnaround time for all<br />
731 samples of 24.9 days. 79% of samples were reported in less than<br />
30 days. 128 clearly pathogenic mutations have been identified in addition<br />
to 121 missense mutations and other unclassified variants. The<br />
Birmingham lab has also performed a number of follow-up studies to<br />
investigate the pathogenicity of missense and unclassified variants as<br />
well as undertaking RNA studies to determine the effect on splicing of<br />
deep intronic variants. The high throughput service has been used by<br />
a number of diagnostic genetics service laboratories and to date 100<br />
reports have been issued to them with an average reporting time of<br />
23 days. This high throughput BRCA sequencing service is available<br />
upon request from the West Midlands Regional <strong>Genetics</strong> Service.<br />
P0040. Familial Breast Cancer With Positive History In Father<br />
And Mother : A Case Report .<br />
R. Habibi;<br />
Royan Institute, Tehran, Islamic Republic of Iran.<br />
Background: A family history of breast cancer in a first-degree relative<br />
is reported in 13% of women with the disease. In turn, over 87% of<br />
women with a family history will not develop breast cancer. However,<br />
only 1% of women have multiple affected relatives, a history suggestive<br />
of a highly penetrant germ-line mutation.<br />
The probability of breast cancer associated with a mutation in BRCA1<br />
and BRCA2 genes increases if there are affected before menopause<br />
and /or have multiple cancers, if there is a case of male, breast cancer,<br />
or if family members also develop ovarian cancer. BRCA2 is associated<br />
more frequently with male breast cancer.<br />
Case report: We report a female case of invasive carcinoma who had<br />
37-year-old, and positive family history with paternal and maternal involvement.<br />
She had fibrosis, inflammation, and fact necrosis in right<br />
breast that negative for malignancy and also she had invasive carcinoma<br />
in left breast. For left breast, lumpectomy was performed .<br />
Conclusions: First, in such a cases probability of the BRCA1 mutation<br />
increases and BRCA2 mutation is possible. Then screening for<br />
these genes should be performed for them and the other members<br />
of relatives and genetic counseling is required, and as soon as clinical<br />
approach for other related cancers may be performed. Second,<br />
also other nongenetic causes in such a family may predispose cancer<br />
susceptibility .